Clinical trial
A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of CNK-UT Cells to Treat the Patients With Steroid-refractory/Resistant or Steroid-dependent GVHD
NCT06568328 is registered in ClinicalTrials.gov with Fujian Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of CNK-UT Cells to Treat the Patients With Steroid-refractory/Resistant or Steroid-dependent GVHD
- Lead sponsor
- Fujian Medical University
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- September 1, 2024
- Completion date
- August 31, 2026
- Enrollment
- 17 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.